Morepen Laboratories Limited has announced the incorporation of a new subsidiary to enhance its capabilities and expand its business operations. The company will hold an 80% equity stake in the new entity, with the remaining 20% owned by members of the promoter group.
The proposed subsidiary will have an authorized and paid-up capital of ₹10 lakh, divided into 1,00,000 equity shares of ₹10 each. The company has committed ₹8 lakh to subscribe to 80,000 shares, while the remaining shares will be held by the promoter group.
The subsidiary will focus on the medical devices sector, aiming to strengthen Morepen’s presence and align with its strategic goals. The entity’s incorporation is part of the company’s broader objectives to enhance capabilities and support business expansion.
The new subsidiary is expected to bring operational and strategic benefits to the company by venturing into a growing industry segment.
